Wolverine Trading, LLC Heron Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $15,311 - $25,476	6,600 Added 58.41%	17,900 $62,000
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $171 - $306	100 Added 0.89%	11,300 $31,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $6,048 - $20,384	11,200 New	11,200 $19,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $109,249 - $298,775	-47,500 Reduced 79.7%	12,100 $38,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $275,948 - $592,424	59,600 New	59,600 $339,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $169,171 - $250,500	-16,700 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$13.27 - $18.48 $31,848 - $44,352	-2,400 Reduced 12.57%	16,700 $261,000
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $76,797 - $109,816	5,300 Added 38.41%	19,100 $292,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $201,618 - $305,532	13,800 New	13,800 $294,000
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $404,632 - $525,992	-29,600 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$10.89 - $21.47 $217,800 - $429,400	-20,000 Reduced 40.32%	29,600 $422,000
Q1 2020 May 11, 2020	BUY	$10.23 - $24.56 $38,874 - $93,328	3,800 Added 8.3%	49,600 $580,000
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $324,012 - $494,946	18,600 Added 68.38%	45,800 $1.08 Million
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $1.04 Million - $1.36 Million	-63,600 Reduced 70.04%	27,200 $533,000
Q2 2019 Aug 20, 2019	BUY	$16.93 - $26.22 $1.21 Million - $1.88 Million	71,600 Added 372.92%	90,800 $1.69 Million
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $717,650 - $878,540	-31,000 Reduced 61.75%	19,200 $469,000
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $74,902 - $108,834	3,400 Added 7.26%	50,200 $1.19 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $615,000 - $837,425	-20,500 Reduced 30.46%	46,800 $1.48 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $576,859 - $901,440	31,300 Added 86.94%	67,300 $1.86 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $34,040 - $43,355	2,300 Added 6.82%	36,000 $652,000
Q3 2017 Nov 15, 2017	BUY	$14.65 - $16.85 $493,705 - $567,845	33,700	33,700 $544,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$42.2 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$14 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$13.2 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$11 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account